225 related articles for article (PubMed ID: 25091592)
1. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
[TBL] [Abstract][Full Text] [Related]
2. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
4. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study.
Shin CM; Kim N; Han K; Kim B; Jung JH; Oh TJ; Lee DH
Cancer Epidemiol; 2020 Feb; 64():101658. PubMed ID: 31887708
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
Kristensen KL; Pottegård A; Hallas J; Rasmussen LM; Lindholt JS
J Vasc Surg; 2017 Sep; 66(3):768-774.e2. PubMed ID: 28506478
[TBL] [Abstract][Full Text] [Related]
8. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
9. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.
Bodmer M; Becker C; Meier C; Jick SS; Meier CR
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):280-6. PubMed ID: 22178569
[TBL] [Abstract][Full Text] [Related]
10. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus.
Smiechowski B; Azoulay L; Yin H; Pollak MN; Suissa S
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1877-83. PubMed ID: 23966577
[TBL] [Abstract][Full Text] [Related]
11. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
13. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study.
Sluggett JK; Koponen M; Bell JS; Taipale H; Tanskanen A; Tiihonen J; Uusitupa M; Tolppanen AM; Hartikainen S
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31778170
[TBL] [Abstract][Full Text] [Related]
14. Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes.
Demb J; Yaseyyedi A; Liu L; Bustamante R; Earles A; Ghosh P; Gutkind JS; Gawron AJ; Kaltenbach TR; Martinez ME; Gupta S
Clin Transl Gastroenterol; 2019 Nov; 10(11):e00092. PubMed ID: 31770138
[TBL] [Abstract][Full Text] [Related]
15. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
[TBL] [Abstract][Full Text] [Related]
16. [Metformin can reduce the risk of colorectal cancer].
Fransgård T; Gögenur I
Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
[TBL] [Abstract][Full Text] [Related]
17. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
18. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
19. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract][Full Text] [Related]
20. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
